SCHEMBL29619258

SCHEMBL29619258

COc1cccc(CCN2C(=O)C(O)=C(C(C)=O)C2c2ccc(Br)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.67
ALOX15 P16050 2/20 0.62
POLB P06746 1/20 0.62
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
SMN1; SMN2 Q16637 2/20 0.57
RXFP1 Q9HBX9 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
LMNA P02545 1/20 0.53
TP53 P04637 2/20 0.53
MDM2 Q00987 2/20 0.53
ALDH1A1 P00352 2/20 0.53
TDP1 Q9NUW8 2/20 0.52
HIF1A Q16665 3/20 0.52
HTT P42858 2/20 0.52
FPR1 P21462 1/20 0.52
MAPT P10636 1/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3706362 1.00 USP7 (0.67) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3705477 0.93 ALOX15 (0.61) USP7ALOX15POLBMEN1KMT2A
SCHEMBL16904825 0.91 ALOX15 (0.63) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3707736 0.90 ALOX15 (0.59) USP7ALOX15POLBMEN1KMT2A
SCHEMBL6781400 0.90 MEN1 (0.72) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3714413 0.88 USP7 (0.73) USP7ALOX15POLBMEN1KMT2A
SCHEMBL15563413 0.88 ALOX15 (0.60) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3706307 0.87 USP7 (0.69) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3707498 0.86 USP7 (0.70) USP7ALOX15POLBMEN1KMT2A
SCHEMBL3705340 0.85 MEN1 (0.78) USP7ALOX15POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220125760-A1 USE OF USP7 INHIBITORS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) UNIVERSITÉ PAUL SABATIER TOULOUSE III (FR) 2022-04-28 US disclosed